126th MAINE LEGISLATURE
LD 802 LR 1245(01)
An Act To Encourage Alternative Forms of Treatment for Opiate or Opioid Addiction by Prohibiting MaineCare Coverage for Medication-assisted Treatment for Addiction
Preliminary Fiscal Impact Statement for Original Bill
Sponsor: Rep. Lockman of Amherst
Committee: Health and Human Services
Fiscal Note Required: Yes
             
Preliminary Fiscal Impact Statement
FY 2013-14 FY 2014-15 Projections  FY 2015-16 Projections  FY 2016-17
Net Cost (Savings)
General Fund $0 ($2,433,062) ($4,866,123) ($4,866,123)
Appropriations/Allocations
General Fund $0 ($2,433,062) ($4,866,123) ($4,866,123)
Federal Expenditures Fund $0 ($3,937,044) ($7,874,087) ($7,874,087)
Fiscal Detail and Notes
The Department of Health and Human Services will experience General Fund savings estimated to be $2,433,062 in fiscal year 2014-15 due to the elimination of MaineCare reimbursement for buprenorphine and naloxone combination drugs and methadone for the treatment of addiction to opioids.